Publication:
Degenerative neurological disorders associated with deficiency of glutamate dehydrogenase

dc.contributor.authorKostic, V.S. (35239923400)
dc.contributor.authorMojsilovic, Lj. (6602818803)
dc.contributor.authorStojanovic, M. (17036830500)
dc.date.accessioned2025-06-12T11:56:49Z
dc.date.available2025-06-12T11:56:49Z
dc.date.issued1989
dc.description.abstractThe activity of glutamate dehydrogenase, the enzyme of glutamate degradation, was measured in platelets of 27 healthy controls and 85 patients with different degenerative cerebellar and/or basal ganglia disorders. A group of 7 patients was selected with slowly progressive multiple-system atrophy, in whom a clinical diagnosis of olivopontocerebellar atrophy appeared tenable, with decreased activity of glutamate dehydrogenase (38% of the mean control value). In 4 patients data on inheritance were compatible with the genetic pattern of autosomal recessive inheritance, while 3 patients were sporadic cases. In an effort to define this group of patients more precisely, it is suggested that decreased activity of glutamate dehydrogenase induces an increase in extracellular glutamate levels in the central nervous system with subsequent development of excitotoxicity. © 1989 Springer-Verlag.
dc.identifier.urihttps://doi.org/10.1007/BF00314407
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0024588176&doi=10.1007%2fBF00314407&partnerID=40&md5=244555391329e5186d1e3bcc7f0b461b
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/1975
dc.subjectGlutamate dehydrogenase
dc.subjectOlivopontocerebellar atrophy
dc.subjectPlatelets
dc.titleDegenerative neurological disorders associated with deficiency of glutamate dehydrogenase
dspace.entity.typePublication

Files